"Himachal Pradesh High Court Overturns Arbitrary Drug License Rejection, Emphasizes Strict Adherence to Rule 79"

In a significant decision yesterday, the Himachal Pradesh High Court, presided over by Justice Ajay Mohan Goel, set aside the rejection of a drug manufacturing license application, highlighting the need for strict compliance with statutory procedures.

The petitioner, Aniketh Jain, had approached the court challenging the orders passed by the Assistant Drug Controller-cum-Licensing Authority, Baddi, and the Appellate Authority. These orders had dismissed his application for a drug manufacturing license under the Drugs and Cosmetics Act, 1940.

Justice Goel, in his landmark ruling, observed that the rejection was "bad in law," as it was based on grounds "totally extraneous" to the scheme of Rule 79 of the Drugs and Cosmetics Rules, 1945. The Court noted, "The application of the petitioner ought to have been processed as per Rule 79 of the 1945 Rules."

This decision underscores the judicial emphasis on the procedural integrity in the grant of drug manufacturing licenses. The Court criticized the Licensing Authority for not conducting the mandatory inspection as required under Rule 79, leading to an unjustified rejection of the application.

"The rejection of the application of the petitioner on the grounds as are contained in the impugned order...is bad in law," Justice Goel remarked, directing the Licensing Authority to reprocess the petitioner's application in compliance with the relevant rules.

The ruling is expected to have significant implications for the pharmaceutical industry in Himachal Pradesh, particularly in ensuring that licensing decisions are made transparently and in strict accordance with the law.

Legal circles are viewing this decision as a crucial precedent in reinforcing the rule of law and procedural fairness in administrative actions, especially in sectors as critical as pharmaceuticals.

The case has been closely watched by industry experts and legal professionals, as it addresses the balance between regulatory diligence and the rights of applicants seeking to enter the pharmaceutical sector.

The petitioner was represented by senior counsel, whose arguments played a pivotal role in highlighting the procedural lapses in the licensing process. On the other hand, the respondent, represented by the Learned Law Officer, defended the actions of the Licensing Authority.

This judgement is not only a victory for the petitioner but also serves as a guiding beacon for authorities in adhering to legal standards, thereby ensuring fairness and transparency in the administrative processes related to public health and safety.

Date of Decision: 22.12.2023

ANIKETH JAIN Vs STATE OF HIMACHAL PRADESH AND ANOTHER